2022-01-05
TED Talk: The Future of Medicine—Healing with Cells, Not Pills!
The future of medicine will transform the way we treat diseases. Soon, we’ll be using cell-based therapies instead of pills.
+2021-12-20
On December 18, 2021, the 5th session of the 4th Council Meeting of the China Association of Traditional Chinese Medicine was held in Beijing. During the meeting, the 2021 Annual Information on the TCM Industry was officially unveiled via live-streaming online. Notably, Jiuzhitang Shuxuetong Injection, Liuwei Dihuang Wan, and Tianma Gouteng Granules proudly made it onto the 2021 List of Clinically Valuable Brands of Traditional Chinese Medicines!
+2021-12-20
Jiuzhitang ranked 26th among the Top 100 Traditional Chinese Medicine Brands in 2021!
On December 18, 2021, the 5th session of the 4th Council Meeting of the China Association of Traditional Chinese Medicine was held in Beijing. During the meeting, Liu Zhanglin, Vice President of the China Association of Traditional Chinese Medicine, officially unveiled the 2021 Top 100 List of Traditional Chinese Patent Medicines via online livestream. Notably, Jiuzhitang Co., Ltd. was honorably recognized, ranking 26th on the list!
+2021-11-09
Messi recently underwent stem cell therapy in Madrid.
During the previous match between Paris Saint-Germain and Lille, Messi was substituted by teammate Icardi in the second half due to an injury. After the game, PSG officially announced that Messi is experiencing discomfort in his left hamstring and pain in his knee. As a result, Messi has chosen to undergo stem-cell therapy in Madrid, focusing on rehabilitating damaged tendons, muscles, and other affected tissues to facilitate full recovery.
+2021-10-20
Jiuzhitang has been honored as a "Pioneer of Independent Innovation in China's Pharmaceutical Industry (50) – Private Enterprises," a "Top 100 Chinese Pharmaceutical Manufacturing Companies," and one of the "Top 50 Chinese Chain Drugstore Enterprises." Meanwhile, Li Zhenguo, Chairman of Jiuzhitang Co., Ltd. and President of Jiuzhitang Group, has earned the prestigious title of "One of China's Top 10 Leaders in the Pharmaceutical Industry."
+2021-09-09
Stem cells are turning ALS from a "terminal illness" into something more manageable!
Stem cell therapy is already being applied in the treatment of various challenging and hard-to-treat diseases, and has demonstrated groundbreaking achievements in areas such as diabetes, chronic kidney disease, premature ovarian failure, and psoriasis. Looking ahead, it holds great promise to make significant strides in treating even more rare diseases, bringing hope to an increasing number of patients.
+2021-08-11
CCTV Reports | Case Study: Stem Cell Therapy for Hereditary Cerebellar Atrophy
The true story described above highlights the promising potential of stem cell technology in treating cerebellar atrophy, a condition for which current medical approaches still fall short of offering effective solutions. With the rise of regenerative medicine, stem cells have emerged as a groundbreaking avenue for addressing brain atrophy, thanks to their unique biological properties, which are now paving the way for innovative and promising therapeutic strategies. We hope that in the future, more patients will benefit from stem cell technology, enabling them to regain their health and quality of life.
+2021-07-29
Serbian Radio: Agüero opts for stem cell therapy to address his knee injury
According to Spain's RAC1 radio, Barcelona's new signing Aguero, who is currently on vacation, is undergoing stem-cell therapy on his knee to regenerate cartilage and potentially extend his playing career.
+2021-07-23
On July 21, the highly anticipated 2021 MSCI Conference—China Pharmaceutical & Health Industry Symbiosis Summit kicked off in Kunming, drawing significant attention from the pharmaceutical industry. The highlight of the event was the grand unveiling of the 2020 China Top 100 Pharmaceutical Companies list, where Jiuzhitang Co., Ltd. made it onto the "2020 China Traditional Chinese Medicine Enterprises TOP100 Ranking," securing the 28th position.
+